REQUEST A DEMO
Total
USD $0.00
Search more companies

Servie AO (Russia)

Main Activities: Health and Personal Care Stores
Secondary Activities: Professional, Scientific, and Technical Services | Management, Scientific, and Technical Consulting Services | Advertising, Public Relations, and Related Services
Full name: Servie AO Profile Updated: August 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

The Russian office of French pharmaceutical company founded by Dr. Jacques Servier in 1954. Currently, Servier Research Group is the second largest French pharmaceutical company in the world with a staff consisting of more than 20,000 people worldwide, of which 3,000 are engaged in research activities. 25% of the company’s turnover is invested in research and clinical studies. In Russia the company has been working for over 30 years. In 1984 first contract for the supply of the drug Diabeton to the Soviet Union was concluded. In 1992 a representative office was opened in Russia. Servier in Russia today is one of the leaders in the prescription drugs niche with more than 1,000 employees in 56 cities of Russia.

Headquarters
Lesnaya, 7, 7/8/9
Moscow; Moscow; Postal Code: 125196

Contact Details: Purchase the Servie AO report to view the information.

Website: http://servier.com

Basic Information
Total Employees:
Purchase the Servie AO report to view the information.
Outstanding Shares:
Purchase the Servie AO report to view the information.
Registered Capital:
Purchase the Servie AO report to view the information.
Incorporation Date:
October 23, 2002
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Regionalnyi Nauchno-Konsultatsionnyi Tsentr Zdravoohranenie ZAO
30%
Company Performance
Financial values in the chart are available after Servie AO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
14.19%
Total operating revenue
14.19%
Operating profit (EBIT)
142.34%
Net Profit (Loss) for the Period
175.77%
Total assets
10.56%
Total equity
16.28%
Operating Profit Margin (ROS)
6.35%
Net Profit Margin
4.06%
Return on Equity (ROE)
8.1%
Quick Ratio
0.57%
Cash Ratio
0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?